BIOGEN INC 405 Market Value
| 09062XAF0 | 98.35 1.09 1.10% |
| Symbol | BIOGEN |
BIOGEN 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BIOGEN's bond what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BIOGEN.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in BIOGEN on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding BIOGEN INC 405 or generate 0.0% return on investment in BIOGEN over 30 days. BIOGEN is related to or competes with Dave Busters, EnVVeno Medical, Repligen, Harmony Gold, Inflection Point, and Merit Medical. More
BIOGEN Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BIOGEN's bond current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BIOGEN INC 405 upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.26) | |||
| Maximum Drawdown | 4.0 | |||
| Value At Risk | (0.56) | |||
| Potential Upside | 0.4238 |
BIOGEN Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BIOGEN's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BIOGEN's standard deviation. In reality, there are many statistical measures that can use BIOGEN historical prices to predict the future BIOGEN's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.11) | |||
| Treynor Ratio | 2.07 |
BIOGEN INC 405 Backtested Returns
BIOGEN INC 405 secures Sharpe Ratio (or Efficiency) of -0.0803, which signifies that the bond had a -0.0803% return per unit of risk over the last 3 months. BIOGEN INC 405 exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BIOGEN's mean deviation of 0.2868, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The bond shows a Beta (market volatility) of -0.0109, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning BIOGEN are expected to decrease at a much lower rate. During the bear market, BIOGEN is likely to outperform the market.
Auto-correlation | -0.11 |
Insignificant reverse predictability
BIOGEN INC 405 has insignificant reverse predictability. Overlapping area represents the amount of predictability between BIOGEN time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BIOGEN INC 405 price movement. The serial correlation of -0.11 indicates that less than 11.0% of current BIOGEN price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
BIOGEN INC 405 lagged returns against current returns
Autocorrelation, which is BIOGEN bond's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BIOGEN's bond expected returns. We can calculate the autocorrelation of BIOGEN returns to help us make a trade decision. For example, suppose you find that BIOGEN has exhibited high autocorrelation historically, and you observe that the bond is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BIOGEN regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BIOGEN bond is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BIOGEN bond is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BIOGEN bond over time.
Current vs Lagged Prices |
| Timeline |
BIOGEN Lagged Returns
When evaluating BIOGEN's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BIOGEN bond have on its future price. BIOGEN autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BIOGEN autocorrelation shows the relationship between BIOGEN bond current value and its past values and can show if there is a momentum factor associated with investing in BIOGEN INC 405.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BIOGEN Bond
BIOGEN financial ratios help investors to determine whether BIOGEN Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIOGEN with respect to the benefits of owning BIOGEN security.